How to Cite
Abstract
The analysis of long-term results of surgical treatment of 198 patients with non-small cell lung cancer (NSCLC) I -III stages. Bronchoplasty (BP) interventions were performed in 99 cases, the control group comprised 99 patients after pneumonectomies (PE) corresponding to the main prognostic criteria for patients after BP interventions. A 1-year, 3-year and 5-year observed survival rates of patients were 87.7%, 56.2% and 44.6% after BP versus 82.8%, 54.6% and 35.9% after PE, respectively. A 1-year, 3-year and 5-year disease-free survival in the BP group was 87.9%, 64.2% and 52.3% versus 88.1%, 61.6% and 37.9% in the PE group. The median of overall and disease-free survival was 51.4 and 55.2 months in the BP group versus 46.2 and 41.0 months in the PE group, respectively.References
Мерабишвили В.М., Дятченко О.Т. Статистика рака легкого (заболеваемость, смертность, выживаемость) // Практическая онкология. - 2000. - № 3. - С. 3-7.
Bagan P., Berna P, Pereira J.C. et al. Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 2046-2050.
Berry M.F., Worni M., Wang X. et al. Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival // Ann. Thorac. Surg. - 2014. - Vol. 97. - P 230 - 235.
Bogot N.R., Quint L.E. Imaging of recurrent lung cancer // Cancer Imaging. - 2004. - Vol. 4. - № 2. - P. 61-67.
Deslauriers J., Gregoire J., Jacques L.F. et al. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences // Ann. Thorac. Surg. - 2004. - Vol. 77. - P. 1152 -1156.
Gaissert H.A., Mathisen D.J., Moncure A.C. et al. Survival and function after sleeve lobectomy for lung cancer // J. Thorac. Cardiovasc. Surg. - 1996. - Vol. 11. - P. 948 - 953.
Ghiribelli C., Voltolini L., Luzzi L. et al. Survival after bronchoplastic lobectomy for non-small cell lung cancer compared with pneumonectomy according to nodal status // J. Cardiovasc. Surg. - 2002. - Vol. 43. - P. 103 - 108.
Kim YT., Kang C.H., Sung S.W., Kim J.H. Local control of disease related to lymph node involvement in nonsmall cell lung cancer after sleeve lobectomy compared with pneumonectomy // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 1153 - 1161.
Ludwig C., Stoelben E., Olschewski M., Hasse J. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma // Ann. Thorac. Surg. -2005. - Vol. 79. - P. 968 - 975.
Okada M., Yamagishi H., Stake S. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy // J. Thorac. Cardiovasc. Surg. - 2000. - Vol. 119. - P. 814 - 819.
Parissis H., Leotsinidis M., Hughes A. Comparative analysis and outcomes of sleeve resection versus pneumonectomy // Asian Cardiovasc. Thorac. Ann. - 2009. - Vol. 17. - № 2. - P. 175 - 182.
Takeda S., Maeda H., Koma M. et al. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 29. - № 3. - P 276.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2017